Efficacy and safety of dupilumab in children aged ≥6 months to <6 years with moderate-to-severe atopic dermatitis

被引：0
|
作者：
Paller, Amy S.
Siegfried, Elaine C.
Simpson, Eric L.
Wollenberg, Andreas
Gonzalez, Mercedes E.
Sidbury, Robert
Lockshin, Benjamin
Xiao, Jing
O'Malley, John T.
Bansal, Ashish
机构：
来源：
ALLERGY AND ASTHMA PROCEEDINGS | 2022年 / 43卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：561 / 561
页数：1
相关论文
共 50 条
  • [41] Pharmacokinetics, safety, and efficacy of dupilumab in children aged ≥2 to <6 years with severe uncontrolled atopic dermatitis (LIBERTY AD PRE-SCHOOL)
    Simpson, Eric L.
    Kamal, Mohamed Ahmed
    Davis, John D.
    Sun, Xian
    Gadkari, Abhijit
    Eckert, Laurent
    Rossi, Ana Beatris
    Bansal, Ashish
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB19 - AB19
  • [42] Pharmacokinetics, safety and efficacy of dupilumab in children aged ≥ 2 to < 6 years with severe, uncontrolled atopic dermatitis (LIBERTY AD PRE-SCHOOL)
    Simpson, E. L.
    Lockshin, B.
    Kamal, M.
    Davis, J. D.
    Sun, X.
    Gadkari, A.
    Rossi, A. B.
    Bansal, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (04) : E95 - E96
  • [43] Dupilumab treatment reduces caregiver-reported skin pain in patients with moderate-to-severe atopic dermatitis aged 6 months to 5 years
    Paller, Amy S.
    Silverberg, Jonathan I.
    Gonzalez, Mercedes E.
    Schneider, Lynda C.
    Sidbury, Robert
    Chen, Zhen
    Bansal, Ashish
    Wang, Zhixiao
    Prescilla, Randy
    FRONTIERS IN PEDIATRICS, 2024, 12
  • [44] Dupilumab treatment normalizes skin barrier function and symptoms in children aged 6-11 years with moderate-to-severe atopic dermatitis
    Leung, D. Y.
    Cork, M. J.
    Ong, P.
    Danby, S.
    Ramirez-Gama, M.
    Garcia, S.
    Taylor, P.
    Zahn, J.
    Bologna, G.
    Zhang, A.
    ALLERGY, 2023, 78 : 194 - 194
  • [45] Dupilumab Efficacy and Safety in Adolescents with Moderate-to-Severe Atopic Dermatitis: A Case Series
    Mareschal, Adrien
    Puzenat, Eve
    Aubin, Francois
    ACTA DERMATO-VENEREOLOGICA, 2020, 100 (01)
  • [46] Laboratory safety from a 16-week phase III study of dupilumab in patients aged 6months-5years with moderate-to-severe atopic dermatitis
    Paller, Amy S.
    Cork, Michael J.
    Wollenberg, Andreas
    Siegfried, Elaine C.
    Gonzalez, Mercedes E.
    Lockshin, Benjamin
    Khokhar, Faisal A.
    Chen, Zhen
    Gonzalez, Tayler
    Simcox, Elizabeth
    Prescilla, Randy
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [47] Effectiveness and Safety of Dupilumab in Children Under 6 Years of Age with Moderate-to-Severe Atopic Dermatitis: A Retrospective Real-World Study
    Berna-Rico, Emilio
    Fiz-Benito, Esther
    Busto-Leis, Jose Manuel
    Servera-Negre, Guillermo
    de Lucas-Laguna, Raul
    Feito-Rodriguez, Marta
    DERMATOLOGY, 2024, 240 (02) : 337 - 342
  • [48] Dupilumab treatment reduces total IgE levels in patients 6 months and older with moderate-to-severe atopic dermatitis
    Siegfried, Elaine C.
    Cork, Michael J.
    Boguniewicz, Mark
    Deleuran, Mette
    Simpson, Eric L.
    Chen, Zhen
    Clearfield, Drew
    Shah, Parul
    Rodriguez Marco, Ainara
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [49] A phase 2, open-label study of single-dose dupilumab in children aged 6 months to <6 years with severe uncontrolled atopic dermatitis: pharmacokinetics, safety and efficacy
    Paller, A. S.
    Siegfried, E. C.
    Simpson, E. L.
    Cork, M. J.
    Lockshin, B.
    Kosloski, M. P.
    Kamal, M. A.
    Davis, J. D.
    Sun, X.
    Pirozzi, G.
    Graham, N. M. H.
    Gadkari, A.
    Eckert, L.
    Ruddy, M.
    Bansal, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (02) : 464 - 475
  • [50] Dupilumab Treatment Reduces Total IgE Levels in Patients 6 Months and Older with Moderate-to-Severe Atopic Dermatitis
    Siegfried, Elaine
    Cork, Michael
    Boguniewicz, Mark
    Deleuran, Mette
    Simpson, Eric
    Chen, Zhen
    Clearfield, Drew
    Shah, Parul
    Rodriguez-Marco, Ainara
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB149 - AB149
12345